176 related articles for article (PubMed ID: 33761659)
1. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
[TBL] [Abstract][Full Text] [Related]
6. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
8. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
9. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
[TBL] [Abstract][Full Text] [Related]
10. MEG3 inhibits cell proliferation, invasion and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma.
Zhao YQ; Liu XB; Xu H; Liu S; Wang JM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2062-2068. PubMed ID: 30915750
[TBL] [Abstract][Full Text] [Related]
11. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma.
Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M
J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565
[TBL] [Abstract][Full Text] [Related]
12. β-Arrestin-1 expression and epithelial-to-mesenchymal transition in laryngeal carcinoma.
Marioni G; Nicolè L; Cappellesso R; Marchese-Ragona R; Fasanaro E; Di Carlo R; La Torre FB; Nardello E; Sanavia T; Ottaviano G; Fassina A
Int J Biol Markers; 2019 Mar; 34(1):33-40. PubMed ID: 30854928
[TBL] [Abstract][Full Text] [Related]
13. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.
Liu S; Zhou F; Shen Y; Zhang Y; Yin H; Zeng Y; Liu J; Yan Z; Liu X
Oncotarget; 2016 May; 7(22):32876-92. PubMed ID: 27096955
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
Wang H; Qian J; Xia X; Ye B
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
[TBL] [Abstract][Full Text] [Related]
16. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
17. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
18. PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway.
Deng B; Zhang S; Zhou Y; Zhu Y; Fei J; Li A
Histochem Cell Biol; 2023 May; 159(5):439-451. PubMed ID: 36602585
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
20. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma.
Zhu GJ; Song PP; Zhou H; Shen XH; Wang JG; Ma XF; Gu YJ; Liu DD; Feng AN; Qian XY; Gao X
Oncol Lett; 2018 Mar; 15(3):3472-3481. PubMed ID: 29467869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
